Literature DB >> 2207419

Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study.

P S Patki1, J Singh, S V Gokhale, P M Bulakh, D S Shrotri, B Patwardhan.   

Abstract

OBJECTIVE: To evaluate the antihypertensive activity of potassium given alone or in combination with magnesium in patients with mild hypertension.
DESIGN: A double blind, randomised, placebo controlled, crossover trial of 32 weeks' duration. SETTINGS: Cardiology outpatient department, Sassoon General Hospitals, Pune, India. PATIENTS: 37 Adults with mild hypertension (diastolic blood pressure less than 110 mm Hg). INTERVENTION: Patients received either placebo or potassium 60 mmol/day alone or in combination with magnesium 20 mmol/day in a crossover design. No other drug treatment was allowed. MEASUREMENTS: Blood pressure and heart rate assessed at weekly intervals and biochemical parameters at monthly intervals.
RESULTS: Potassium alone or in combination with magnesium produced a significant reduction in systolic and diastolic blood pressures (p less than 0.001) and a significant reduction in serum cholesterol concentration (p less than 0.05); other biochemical variables did not change. Magnesium did not have an additional effect. Urinary potassium excretion increased significantly in the groups who received potassium alone or in combination with magnesium. The drug was well tolerated and compliance was satisfactory.
CONCLUSION: Potassium 60 mmol/day lowers arterial blood pressure in patients with mild hypertension. Giving magnesium as well has no added advantage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207419      PMCID: PMC1663843          DOI: 10.1136/bmj.301.6751.521

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  20 in total

1.  The mechanism of the vasodilator action of potassium.

Authors:  W T Chen; R A Brace; J B Scott; D K Anderson; F J Haddy
Journal:  Proc Soc Exp Biol Med       Date:  1972-07

2.  Direct effects of potassium on renin secretion and renal function.

Authors:  A J Vander
Journal:  Am J Physiol       Date:  1970-08

3.  Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension.

Authors:  L P Svetkey; W E Yarger; J R Feussner; E DeLong; P E Klotman
Journal:  Hypertension       Date:  1987-05       Impact factor: 10.190

4.  Re-analysis of data in two Lancet papers on the effect of dietary sodium and potassium on blood pressure.

Authors:  J M Holly; F J Goodwin; S J Evans; M J VandenBurg; J M Ledingham
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

5.  Controlled trial of long term oral potassium supplements in patients with mild hypertension.

Authors:  A Siani; P Strazzullo; L Russo; S Guglielmi; L Iacoviello; L A Ferrara; M Mancini
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

6.  Serum and erythrocyte magnesium in normal elderly danish people. Relationship to blood pressure and serum lipids.

Authors:  B Petersen; M Schroll; C Christiansen; I Transbol
Journal:  Acta Med Scand       Date:  1977-01

7.  Increased blood pressure during potassium depletion in normotensive men.

Authors:  G G Krishna; E Miller; S Kapoor
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

8.  Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects.

Authors:  W G Walker; P K Whelton; H Saito; R P Russell; J Hermann
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

9.  Whole body measurements of sodium turnover in offspring of patients with sustained essential hypertension.

Authors:  N C Henningsen; O Ohlsson; S Mattson; B Nosslin
Journal:  Eur J Nucl Med       Date:  1982

10.  Attenuated vasodilator responses to K+ in essential hypertensive men.

Authors:  H W Overbeck; R S Derifield; M B Pamnani; T Sözen
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more
  19 in total

1.  Potassium and magnesium in essential hypertension.

Authors:  C O'Callaghan; L Howes
Journal:  BMJ       Date:  1990-11-17

2.  Potassium and magnesium in essential hypertension.

Authors:  P S Patki; G S Gokhale; J Singh; D S Shrotri; B Patwardhan
Journal:  BMJ       Date:  1990-12-01

Review 3.  Hypertension.

Authors:  G W Ching; D G Beevers
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

4.  Association of hypermagnesemia and blood pressure in the critically ill.

Authors:  Leo A Celi; Daniel J Scott; Joon Lee; Rachel Nelson; Seth L Alper; Kenneth J Mukamal; Roger G Mark; John Danziger
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

Review 5.  Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence.

Authors:  Kristal J Aaron; Paul W Sanders
Journal:  Mayo Clin Proc       Date:  2013-09       Impact factor: 7.616

6.  Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  E Burgess; R Lewanczuk; P Bolli; A Chockalingam; H Cutler; G Taylor; P Hamet
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 7.  Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research.

Authors:  Beth H Rice; Christopher J Cifelli; Matthew A Pikosky; Gregory D Miller
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 8.  Non-pharmacological aspects of blood pressure management: what are the data?

Authors:  S Susan Hedayati; Essam F Elsayed; Robert F Reilly
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

9.  Acute dairy milk ingestion does not improve nitric oxide-dependent vasodilation in the cutaneous microcirculation.

Authors:  Billie K Alba; Anna E Stanhewicz; W Larry Kenney; Lacy M Alexander
Journal:  Br J Nutr       Date:  2016-05-16       Impact factor: 3.718

Review 10.  The role of magnesium in hypertension and cardiovascular disease.

Authors:  Mark Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-09-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.